An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent.
Identifieur interne : 000B04 ( PubMed/Corpus ); précédent : 000B03; suivant : 000B05An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent.
Auteurs : Suzanne L. Parker ; Yarmarly C. Guerra Valero ; Jenny L. Ord Ez Mejia ; Claire Roger ; Jeffrey Lipman ; Jason A. Roberts ; Steven C. WallisSource :
- Bioanalysis [ 1757-6199 ] ; 2017.
Abstract
Critical illness and medical interventions, such as renal replacement therapy, can cause changes to vancomycin pharmacokinetics and lead to suboptimal dosing. To comprehensively characterize vancomycin pharmacokinetic a method must measure vancomycin in a range of clinical matrices.
DOI: 10.4155/bio-2017-0019
PubMed: 28617036
Links to Exploration step
pubmed:28617036Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent.</title><author><name sortKey="Parker, Suzanne L" sort="Parker, Suzanne L" uniqKey="Parker S" first="Suzanne L" last="Parker">Suzanne L. Parker</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Guerra Valero, Yarmarly C" sort="Guerra Valero, Yarmarly C" uniqKey="Guerra Valero Y" first="Yarmarly C" last="Guerra Valero">Yarmarly C. Guerra Valero</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Ord Ez Mejia, Jenny L" sort="Ord Ez Mejia, Jenny L" uniqKey="Ord Ez Mejia J" first="Jenny L" last="Ord Ez Mejia">Jenny L. Ord Ez Mejia</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name><affiliation><nlm:affiliation>CHU Nimes, Serv Reanimat, Pole Anesthesie Reanimat Douleur Urgence, Nimes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Lipman, Jeffrey" sort="Lipman, Jeffrey" uniqKey="Lipman J" first="Jeffrey" last="Lipman">Jeffrey Lipman</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Wallis, Steven C" sort="Wallis, Steven C" uniqKey="Wallis S" first="Steven C" last="Wallis">Steven C. Wallis</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28617036</idno><idno type="pmid">28617036</idno><idno type="doi">10.4155/bio-2017-0019</idno><idno type="wicri:Area/PubMed/Corpus">000B04</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B04</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent.</title><author><name sortKey="Parker, Suzanne L" sort="Parker, Suzanne L" uniqKey="Parker S" first="Suzanne L" last="Parker">Suzanne L. Parker</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Guerra Valero, Yarmarly C" sort="Guerra Valero, Yarmarly C" uniqKey="Guerra Valero Y" first="Yarmarly C" last="Guerra Valero">Yarmarly C. Guerra Valero</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Ord Ez Mejia, Jenny L" sort="Ord Ez Mejia, Jenny L" uniqKey="Ord Ez Mejia J" first="Jenny L" last="Ord Ez Mejia">Jenny L. Ord Ez Mejia</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Roger, Claire" sort="Roger, Claire" uniqKey="Roger C" first="Claire" last="Roger">Claire Roger</name><affiliation><nlm:affiliation>CHU Nimes, Serv Reanimat, Pole Anesthesie Reanimat Douleur Urgence, Nimes, France.</nlm:affiliation></affiliation></author><author><name sortKey="Lipman, Jeffrey" sort="Lipman, Jeffrey" uniqKey="Lipman J" first="Jeffrey" last="Lipman">Jeffrey Lipman</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author><author><name sortKey="Wallis, Steven C" sort="Wallis, Steven C" uniqKey="Wallis S" first="Steven C" last="Wallis">Steven C. Wallis</name><affiliation><nlm:affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Bioanalysis</title><idno type="eISSN">1757-6199</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Critical illness and medical interventions, such as renal replacement therapy, can cause changes to vancomycin pharmacokinetics and lead to suboptimal dosing. To comprehensively characterize vancomycin pharmacokinetic a method must measure vancomycin in a range of clinical matrices.</div></front></TEI><pubmed><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">28617036</PMID><DateCreated><Year>2017</Year><Month>06</Month><Day>15</Day></DateCreated><DateRevised><Year>2017</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1757-6199</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Bioanalysis</Title><ISOAbbreviation>Bioanalysis</ISOAbbreviation></Journal><ArticleTitle>An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent.</ArticleTitle><Pagination><MedlinePgn>911-924</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4155/bio-2017-0019</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Critical illness and medical interventions, such as renal replacement therapy, can cause changes to vancomycin pharmacokinetics and lead to suboptimal dosing. To comprehensively characterize vancomycin pharmacokinetic a method must measure vancomycin in a range of clinical matrices.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A LC-MS/MS method was developed using hydrophilic interaction liquid chromatography and microsample volumes, where possible. For all matrices, the linear concentration range was 1-100 μg/ml, interassay accuracy and precision was within 15%, and recovery above 80%. No matrix effects were observed. Calibration equivalence may be applied for some matrix combinations.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A method for the analysis of vancomycin in plasma (total, unbound), urine and renal replacement therapy effluent, suitable for use in any patient pharmacokinetic study, has been developed and validated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Suzanne L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guerra Valero</LastName><ForeName>Yarmarly C</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ordóñez Mejia</LastName><ForeName>Jenny L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roger</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>CHU Nimes, Serv Reanimat, Pole Anesthesie Reanimat Douleur Urgence, Nimes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Brisbane & Women's Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health, Queensland University of Technology, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health, Queensland University of Technology, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, Royal Brisbane & Women's Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Translational Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallis</LastName><ForeName>Steven C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Burns, Trauma & Critical Care Research Centre, UQ Centre for Clinical Research, Brisbane, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Bioanalysis</MedlineTA><NlmUniqueID>101512484</NlmUniqueID><ISSNLinking>1757-6180</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dialysis</Keyword><Keyword MajorTopicYN="N">mass spectrometry</Keyword><Keyword MajorTopicYN="N">pharmacodynamics</Keyword><Keyword MajorTopicYN="N">pharmacokinetic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28617036</ArticleId><ArticleId IdType="doi">10.4155/bio-2017-0019</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000B04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:28617036
|texte= An LC-MS/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28617036" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |